EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS073-06673 
Organism
Homo sapiens 
Tissue/cell
GM19238 
Coordinate
chr17:76754750-76756560 
Target genes
Number: 3             
NameEnsembl ID
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
IRF1MA0050.2chr17:76754811-76754832AAAGAAAAAAAGAAAGGAAAG-6.28
IRF1MA0050.2chr17:76754799-76754820AAAACAAAAAAGAAAGAAAAA-6.46
Myod1MA0499.1chr17:76755530-76755543AGCAACAGCTGCA-6.64
Number of super-enhancer constituents: 30             
IDCoordinateTissue/cell
SE_09291chr17:76753984-76756575CD14
SE_10232chr17:76752298-76756594CD19_Primary
SE_10917chr17:76751138-76759481CD20
SE_11911chr17:76752262-76756533CD3
SE_13166chr17:76754727-76756430CD34_Primary_RO01480
SE_13786chr17:76754583-76756366CD34_Primary_RO01536
SE_14447chr17:76753823-76756459CD4_Memory_Primary_7pool
SE_15851chr17:76753860-76756483CD4_Naive_Primary_7pool
SE_16882chr17:76753872-76756526CD4p_CD225int_CD127p_Tmem
SE_17330chr17:76737257-76756438CD4p_CD25-_CD45RAp_Naive
SE_17789chr17:76752161-76756541CD4p_CD25-_CD45ROp_Memory
SE_18275chr17:76708858-76756450CD4p_CD25-_Il17-_PMAstim_Th
SE_19133chr17:76751388-76756545CD4p_CD25-_Il17p_PMAstim_Th17
SE_20047chr17:76738945-76758607CD56
SE_20904chr17:76753941-76756405CD8_Memory_7pool
SE_21491chr17:76753776-76756440CD8_Naive_7pool
SE_22344chr17:76730576-76756522CD8_primiary
SE_26201chr17:76754539-76756453Duodenum_Smooth_Muscle
SE_26756chr17:76754730-76755671Esophagus
SE_30589chr17:76754957-76756339Fetal_Muscle
SE_32461chr17:76754745-76756452GM12878
SE_43543chr17:76754397-76756439MM1S
SE_50271chr17:76754657-76756419Sigmoid_Colon
SE_52658chr17:76754612-76756440Small_Intestine
SE_53636chr17:76754642-76756414Spleen
SE_60415chr17:76679151-76756346DHL6
SE_60995chr17:76690240-76779668HBL1
SE_61668chr17:76693174-76787177Toledo
SE_62236chr17:76690401-76817069Tonsil
SE_67253chr17:76754397-76756439MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr177675477676755666
chr177675533076755871
Enhancer Sequence
TGTATTCCAG CCTGGGCAAC AAGAGTGAAA CTCGAAACTC CATCTCAAAA AAACAAAAAA 60
GAAAGAAAAA AAGAAAGGAA AGTGCTAAGT CCTTGGTGGT CCTTGGTTCC TCAGCTGTAG 120
GCAAACCCAA TTCATGCATA GACATCATCT GGGCCCATCA TGTCACCCCA CGAGACTTGA 180
GGTCAGGGGC ACCAGCACTT TCATGCTGAT ATTCCTGCTA TTTGCTGTGC GATGTGTACT 240
AATCTGCCTC ATTCTGATCC AGTAGGTCTC GTTATCTACT TTCGGCATCC ACGGAGTTAT 300
GGCATGTGCT TGTGGCCCTA GCTACTCAGG AAGCTGAGGT GGGAGGATTG CTTAAGCATA 360
GGAGATCGAG GTTGCAGTGG GCTATGACAA CACCACTGCA CTCCAGCCTG GTCAACAGAG 420
TGAGATCCTG TCTCAAAACA GAAAGAAAAT TTCCATAATA ATAATTTTCT CAATGTTTGC 480
CAAAGTGCTA AAGTAAGAAG GGCACAATTG TAGCCAATCG AAGCCCACTG CCTGAGGTGG 540
CTTCATTTTC AGACTATATG GCAACTGCCC CGAGGAAGGA CTAAAAGGTA CTCTCCAAAG 600
ACACTCTGGG TAAGTGGACG CAGCCTCAGT TCTTCGTAGG TCTCATGCGC CTAGCAGTCT 660
ACATCCCAGC GCCAAGCCTC TCTTTCATCC AACGGGGTAG GCAAAGGGGT CTTTTTAGGT 720
TGCTTCCTCA CTGTTGTACA GATCAGGGCT CTAAAACTGG CACCTGGCCA CTGGCTGCCT 780
AGCAACAGCT GCAACATAAA GAGACGGTAT CTCTTAAAAG GAACAAAACA GAAAACCACA 840
CAAAGACACA TGGGGAAGCT AAAGTGGGTA GGTAGCTATA TACTTGGTAG CTATAATAAA 900
GGAGTAAAAA CAAAAATCCA AGGTTGGTTA TTCTTGCTTC TTTCATCTGT TGAGCCTCTT 960
CTTAAAAACC TCTGTAAGTT CAAAACCCTC CAAGCGGAAT ACTGAATGGC TTAAAGCAAA 1020
ACCACATAAA TTAGATAGTT ACAGCTGAGG AAATGCATTC AACACTCAGC CATCCCTTCC 1080
TACAATCATG GACGCACAAA TTCTTGTGAA ATCATTTTAT ACACTCAACA CGGGAAATGA 1140
AGGGAAGCAT CTCTGGCCAG GCCAACTCAA GCCAGAGCCT GCCTGTGTGA TGTGACCTTG 1200
GAGAGAACAG TTAGAGGTTC TGAAGCGTGA GTTTCCACAC CTGGGGTCCC CAAATTTAGG 1260
GGCATTAGAA GTATATTTGT GTGCATGTGT GTACAAGCAT GTGCATGTAT GTACGTATTT 1320
ATTCATTCAC TCATTCCTGG ATCTGCCCTG GTACGTTTGG TATGGCTAGA GTAAGGAACC 1380
AGAATAAATG GCTTTTTTGA AAGATTCCTC CAGGGATTCT GCGGGTTAGT CAAGTATGGG 1440
AACCACCATT CTAACCCAAA TTTACTAGAT TACGAACTTT AAAAGGGAAG GCTAAACAAA 1500
CCACTTCTGC ATGTTCATCT GCCTAGGACA TCTGCTACCA CAATTGCAAA AGGTGCCCAT 1560
GTGGAACGGA AAATACATGG TTGAATTTTA CAAATTTAGA CATATAAAGC TAAAAACTCA 1620
AGAAACACTG AATTCCCTCT TTTGACTACT GATGTTTTAA TTCTGGCCTC TATCCAAATA 1680
GCAGGTTTAT ATATATATAT ATATATATAT ATATATACAC ACACATACAT ATATATATGT 1740
GTATATATAT ATATATACAC ATACATATAT ATATGTATAT ATATATACAT ACATATATAT 1800
ATGTATATAT 1810